Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
N.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AZ.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.114NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.199NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.190NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.552NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AF.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.89NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
M.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.333NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.429NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.463NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
U.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.373NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.80NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.433NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.36.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AN.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.221.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.242NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.449NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.152NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.146NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
D.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.11NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.71NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.445NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.21 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AT.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.619.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
P.1.12.1 (Gamma)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
AZ.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.260NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.456NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.160.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.4.16 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.70NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used